Global Point-of-Care Molecular Diagnostics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 1476
  • calendar_today Published On: Feb, 2020
  • file_copy Pages: 108
  • list Pharmaceuticals and Healthcare
Buy @ $3480


Scope of the Report:
The global Point-of-Care Molecular Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Point-of-Care Molecular Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Point-of-Care Molecular Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Point-of-Care Molecular Diagnostics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Danaher Corporation
Johnson and Johnson
BioMerieux
F. Hoffmann-La Roche AG
Abbott Laboratories, Bayer Healthcare
Becton, Dickinson and Company
Cepheid, Inc.
Bio-Rad Laboratories, Inc.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
PCR-based
Genetic Sequencing-based
Hybridization-based
Microarray-based

Market Segment by Applications, can be divided into
Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Other
Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents
1 Point-of-Care Molecular Diagnostics Market Overview
1.1 Product Overview and Scope of Point-of-Care Molecular Diagnostics
1.2 Classification of Point-of-Care Molecular Diagnostics by Types
1.2.1 Global Point-of-Care Molecular Diagnostics Revenue Comparison by Types (2019-2024)
1.2.2 Global Point-of-Care Molecular Diagnostics Revenue Market Share by Types in 2018
1.2.3 PCR-based
1.2.4 Genetic Sequencing-based
1.2.5 Hybridization-based
1.2.6 Microarray-based
1.3 Global Point-of-Care Molecular Diagnostics Market by Application
1.3.1 Global Point-of-Care Molecular Diagnostics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Infectious Diseases
1.3.3 Oncology
1.3.4 Hematology
1.3.5 Prenatal Testing
1.3.6 Endocrinology
1.3.7 Other
1.4 Global Point-of-Care Molecular Diagnostics Market by Regions
1.4.1 Global Point-of-Care Molecular Diagnostics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
1.5 Global Market Size of Point-of-Care Molecular Diagnostics (2014-2024)
2 Company Profiles
2.1 Danaher Corporation
2.1.1 Business Overview
2.1.2 Point-of-Care Molecular Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Danaher Corporation Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Johnson and Johnson
2.2.1 Business Overview
2.2.2 Point-of-Care Molecular Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson and Johnson Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.3 BioMerieux
2.3.1 Business Overview
2.3.2 Point-of-Care Molecular Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioMerieux Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.4 F. Hoffmann-La Roche AG
2.4.1 Business Overview
2.4.2 Point-of-Care Molecular Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 F. Hoffmann-La Roche AG Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Abbott Laboratories, Bayer Healthcare
2.5.1 Business Overview
2.5.2 Point-of-Care Molecular Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Laboratories, Bayer Healthcare Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.6 Becton, Dickinson and Company
2.6.1 Business Overview
2.6.2 Point-of-Care Molecular Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Becton, Dickinson and Company Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.7 Cepheid, Inc.
2.7.1 Business Overview
2.7.2 Point-of-Care Molecular Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cepheid, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.8 Bio-Rad Laboratories, Inc.
2.8.1 Business Overview
2.8.2 Point-of-Care Molecular Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Point-of-Care Molecular Diagnostics Market Competition, by Players
3.1 Global Point-of-Care Molecular Diagnostics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Point-of-Care Molecular Diagnostics Players Market Share
3.2.2 Top 10 Point-of-Care Molecular Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Point-of-Care Molecular Diagnostics Market Size by Regions
4.1 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Regions
4.2 North America Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
4.3 Europe Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
4.5 South America Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
5 North America Point-of-Care Molecular Diagnostics Revenue by Countries
5.1 North America Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
5.2 USA Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
5.3 Canada Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
5.4 Mexico Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
6 Europe Point-of-Care Molecular Diagnostics Revenue by Countries
6.1 Europe Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
6.2 Germany Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
6.3 UK Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
6.4 France Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
6.5 Russia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
6.6 Italy Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Point-of-Care Molecular Diagnostics Revenue by Countries
7.1 Asia-Pacific Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
7.2 China Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
7.3 Japan Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
7.4 Korea Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
7.5 India Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
8 South America Point-of-Care Molecular Diagnostics Revenue by Countries
8.1 South America Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
8.2 Brazil Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
8.3 Argentina Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
8.4 Colombia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Point-of-Care Molecular Diagnostics by Countries
9.1 Middle East and Africa Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
9.3 UAE Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
9.4 Egypt Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
9.6 South Africa Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
10 Global Point-of-Care Molecular Diagnostics Market Segment by Type
10.1 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Type (2014-2019)
10.2 Global Point-of-Care Molecular Diagnostics Market Forecast by Type (2019-2024)
10.3 PCR-based Revenue Growth Rate (2014-2024)
10.4 Genetic Sequencing-based Revenue Growth Rate (2014-2024)
10.5 Hybridization-based Revenue Growth Rate (2014-2024)
10.6 Microarray-based Revenue Growth Rate (2014-2024)
11 Global Point-of-Care Molecular Diagnostics Market Segment by Application
11.1 Global Point-of-Care Molecular Diagnostics Revenue Market Share by Application (2014-2019)
11.2 Point-of-Care Molecular Diagnostics Market Forecast by Application (2019-2024)
11.3 Infectious Diseases Revenue Growth (2014-2019)
11.4 Oncology Revenue Growth (2014-2019)
11.5 Hematology Revenue Growth (2014-2019)
11.6 Prenatal Testing Revenue Growth (2014-2019)
11.7 Endocrinology Revenue Growth (2014-2019)
11.8 Other Revenue Growth (2014-2019)
12 Global Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2024)
12.1 Global Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2024)
12.2 Global Point-of-Care Molecular Diagnostics Market Forecast by Regions (2019-2024)
12.3 North America Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
12.4 Europe Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
12.6 South America Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Point-of-Care Molecular Diagnostics Picture
Table Product Specifications of Point-of-Care Molecular Diagnostics
Table Global Point-of-Care Molecular Diagnostics and Revenue (Million USD) Market Split by Product Type
Figure Global Point-of-Care Molecular Diagnostics Revenue Market Share by Types in 2018
Figure PCR-based Picture
Figure Genetic Sequencing-based Picture
Figure Hybridization-based Picture
Figure Microarray-based Picture
Table Global Point-of-Care Molecular Diagnostics Revenue (Million USD) by Application (2014-2024)
Figure Point-of-Care Molecular Diagnostics Revenue Market Share by Applications in 2018
Figure Infectious Diseases Picture
Figure Oncology Picture
Figure Hematology Picture
Figure Prenatal Testing Picture
Figure Endocrinology Picture
Figure Other Picture
Table Global Market Point-of-Care Molecular Diagnostics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Point-of-Care Molecular Diagnostics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Point-of-Care Molecular Diagnostics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Point-of-Care Molecular Diagnostics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Point-of-Care Molecular Diagnostics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Point-of-Care Molecular Diagnostics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Point-of-Care Molecular Diagnostics Revenue (Million USD) and Growth Rate (2014-2024)
Table Danaher Corporation Basic Information, Manufacturing Base and Competitors
Table Danaher Corporation Point-of-Care Molecular Diagnostics Type and Applications
Table Danaher Corporation Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson and Johnson Point-of-Care Molecular Diagnostics Type and Applications
Table Johnson and Johnson Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table BioMerieux Basic Information, Manufacturing Base and Competitors
Table BioMerieux Point-of-Care Molecular Diagnostics Type and Applications
Table BioMerieux Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table F. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche AG Point-of-Care Molecular Diagnostics Type and Applications
Table F. Hoffmann-La Roche AG Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Laboratories, Bayer Healthcare Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories, Bayer Healthcare Point-of-Care Molecular Diagnostics Type and Applications
Table Abbott Laboratories, Bayer Healthcare Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table Becton, Dickinson and Company Point-of-Care Molecular Diagnostics Type and Applications
Table Becton, Dickinson and Company Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table Cepheid, Inc. Basic Information, Manufacturing Base and Competitors
Table Cepheid, Inc. Point-of-Care Molecular Diagnostics Type and Applications
Table Cepheid, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table Bio-Rad Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Type and Applications
Table Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Point-of-Care Molecular Diagnostics Revenue (Million USD) by Players (2014-2019)
Table Global Point-of-Care Molecular Diagnostics Revenue Share by Players (2014-2019)
Figure Global Point-of-Care Molecular Diagnostics Revenue Share by Players in 2017
Figure Global Point-of-Care Molecular Diagnostics Revenue Share by Players in 2018
Figure Global Top 5 Players Point-of-Care Molecular Diagnostics Revenue Market Share in 2018
Figure Global Top 10 Players Point-of-Care Molecular Diagnostics Revenue Market Share in 2018
Figure Global Point-of-Care Molecular Diagnostics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Point-of-Care Molecular Diagnostics Revenue (Million USD) by Regions (2014-2019)
Table Global Point-of-Care Molecular Diagnostics Revenue Market Share by Regions (2014-2019)
Figure Global Point-of-Care Molecular Diagnostics Revenue Market Share by Regions (2014-2019)
Figure Global Point-of-Care Molecular Diagnostics Revenue Market Share by Regions in 2018
Figure North America Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Europe Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure South America Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Table North America Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
Table North America Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2014-2019)
Figure North America Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2014-2019)
Figure North America Point-of-Care Molecular Diagnostics Revenue Market Share by Countries in 2018
Figure USA Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Canada Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Mexico Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Table Europe Point-of-Care Molecular Diagnostics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2014-2019)
Figure Europe Point-of-Care Molecular Diagnostics Revenue Market Share by Countries in 2018
Figure Germany Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure UK Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure France Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Russia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Italy Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Point-of-Care Molecular Diagnostics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Point-of-Care Molecular Diagnostics Revenue Market Share by Countries in 2018
Figure China Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Japan Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Korea Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure India Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Table South America Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
Table South America Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2014-2019)
Figure South America Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2014-2019)
Figure South America Point-of-Care Molecular Diagnostics Revenue Market Share by Countries in 2018
Figure Brazil Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Argentina Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Colombia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Point-of-Care Molecular Diagnostics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Point-of-Care Molecular Diagnostics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure UAE Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Egypt Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure Nigeria Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Figure South Africa Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
Table Global Point-of-Care Molecular Diagnostics Revenue (Million USD) by Type (2014-2019)
Table Global Point-of-Care Molecular Diagnostics Revenue Share by Type (2014-2019)
Figure Global Point-of-Care Molecular Diagnostics Revenue Share by Type (2014-2019)
Figure Global Point-of-Care Molecular Diagnostics Revenue Share by Type in 2018
Table Global Point-of-Care Molecular Diagnostics Revenue Forecast by Type (2019-2024)
Figure Global Point-of-Care Molecular Diagnostics Market Share Forecast by Type (2019-2024)
Figure Global PCR-based Revenue Growth Rate (2014-2019)
Figure Global Genetic Sequencing-based Revenue Growth Rate (2014-2019)
Figure Global Hybridization-based Revenue Growth Rate (2014-2019)
Figure Global Microarray-based Revenue Growth Rate (2014-2019)
Table Global Point-of-Care Molecular Diagnostics Revenue by Application (2014-2019)
Table Global Point-of-Care Molecular Diagnostics Revenue Share by Application (2014-2019)
Figure Global Point-of-Care Molecular Diagnostics Revenue Share by Application (2014-2019)
Figure Global Point-of-Care Molecular Diagnostics Revenue Share by Application in 2018
Table Global Point-of-Care Molecular Diagnostics Revenue Forecast by Application (2019-2024)
Figure Global Point-of-Care Molecular Diagnostics Market Share Forecast by Application (2019-2024)
Figure Global Infectious Diseases Revenue Growth Rate (2014-2019)
Figure Global Oncology Revenue Growth Rate (2014-2019)
Figure Global Hematology Revenue Growth Rate (2014-2019)
Figure Global Prenatal Testing Revenue Growth Rate (2014-2019)
Figure Global Endocrinology Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Point-of-Care Molecular Diagnostics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Point-of-Care Molecular Diagnostics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Point-of-Care Molecular Diagnostics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
Figure Europe Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
Figure South America Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)